METFORMIN-BASED COMBINATION THERAPY DIFFERENTIALLY MODULATES ADIPONECTIN AND LIPID PROFILE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Objectives: This study aimed to evaluate the effects of different metformin-based combination therapies on circulating adiponectin levels and lipid profile parameters in patients with type 2 diabetes mellitus (T2DM) and to compare the metabolic responses associated with each therapeutic regimen. Methods: A prospective...